Malta vs Puerto Rico: The number of people with susceptibility test result for rifampicin
Malta
93.1
in 2021
Puerto Rico
93.33
in 2021
Malta rank
59th
Puerto Rico rank
58th
The number of people with susceptibility test result for rifampicin over time
- Malta
- Puerto Rico
How they compare
Puerto Rico currently reports 93.33 against 93.1 in Malta, a difference of 0.23.
Across all 5 years both countries report, Puerto Rico has been ahead every year.
Malta ranks 59th and Puerto Rico ranks 58th of 146 countries.
Puerto Rico has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Malta | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 91.41 | 97.81 | 6.41 | Puerto Rico |
| 2020s | 90.14 | 94.49 | 4.35 | Puerto Rico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Malta or Puerto Rico?
- Puerto Rico, at 93.33 against 93.1 in Malta as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Malta and Puerto Rico?
- 0.23, with Puerto Rico ahead.
- How many years of comparable data are there for Malta and Puerto Rico?
- 5 years are reported by both, from 2017 to 2021.
- How do Malta and Puerto Rico rank globally for the number of people with susceptibility test result for rifampicin?
- Malta ranks 59th and Puerto Rico ranks 58th of 146 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid refreshes it automatically from the source and publishes the full history for both places.